Clinical Trial Update: Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell [Phase 1, Phase 2]

View source ↗

Summary

This document describes a Phase 1/2 clinical trial evaluating infusion of expanded allogeneic mesenchymal stem cells to treat refractory graft-versus-host disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Expanded in-Vitro Allogeneic Mesenchymal Stem Cells (mesenchymal stem cells (allogeneic))

Snippet

Sponsor: University of Salamanca | Conditions: Graft-vs-Host Disease (GVHD) | Phase 1, Phase 2 | Status: UNKNOWN